With the potential for an epidemic at hand, we look at things from a glass-half-full perspective.
Let's see what the numbers say about Illumina (ILMN).
Thermo Fisher buys Life Technologies for $13.6 billion, but is it a good deal?
Who's going to win the bidding war over Life Technologies, and will it pay off big for investors?
Let's look forward to this company's next earnings report.
Market-lagging returns could be written in this 2-Star.
Finding companies that have all the right stuff can produce winners.
Will PacBio's Q4 results slow the stock's big 2013 surge?
What's gotten into Hansen Medical and Pacific Biosciences?
Market-trouncing returns could be written in this 5-Star.